ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,463,000 | +609.5% | 358,800 | +321.1% | 0.11% | +286.2% |
| Q2 2016 | $629,000 | -1.1% | 85,200 | -14.5% | 0.03% | -6.5% |
| Q1 2016 | $636,000 | +69.6% | 99,600 | +65.7% | 0.03% | +34.8% |
| Q4 2015 | $375,000 | -72.9% | 60,100 | -74.6% | 0.02% | -77.9% |
| Q3 2015 | $1,383,000 | +178.3% | 236,900 | +292.2% | 0.10% | +116.7% |
| Q1 2015 | $497,000 | +48.4% | 60,400 | +23.5% | 0.05% | -7.7% |
| Q4 2014 | $335,000 | -68.1% | 48,900 | -14.4% | 0.05% | -44.7% |
| Q3 2013 | $1,050,000 | – | 57,100 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |